참고문헌
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2018;68:394-424. https://doi.org/10.3322/caac.21492
- Abramson S, Weissmann G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Clinical and Experimental Rheumatology 1989;7:S163-170.
- Chen C-N, Sung C-T, Lin M-T, Lee P-H, Chang K-J. Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma. Annals of Surgery 2001;233:183. https://doi.org/10.1097/00000658-200102000-00006
- Seibert K, Zhang Y, Leahy K, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proceedings of the National Academy of Sciences 1994;91:12013-12017. https://doi.org/10.1073/pnas.91.25.12013
- Cosme R, Lublin D, Takafuji V, Lynch K, Roche JK. Prostanoids in human colonic mucosa: effects of inflammation on PGE2 receptor expression. Human Immunology 2000;61:684-696. https://doi.org/10.1016/S0198-8859(00)00131-2
- Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. The Lancet Oncology 2012;13:518-527. https://doi.org/10.1016/S1470-2045(12)70112-2
- Elwood PC, Gallagher AM, Duthie GG, Mur LA, Morgan G. Aspirin, salicylates, and cancer. The Lancet 2009;373:1301-1309. https://doi.org/10.1016/S0140-6736(09)60243-9
- Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A. Inhibition of development of Methylinitrosourea-induced rat colon tumors by Indomethacin treatment. Cancer Research 1981;41:1954-1957.
- Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Research 1988;48:4399-4404.
- Tsuji S, Kawano S, Sawaoka H, et al. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins, Leukotrienes and Essential fatty acids 1996;55:179-183. https://doi.org/10.1016/S0952-3278(96)90095-2
- Joo Y-E, Chung I-J, Park Y-K, et al. Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer. Journal of Korean Medical Science 2006;21:871-876. https://doi.org/10.3346/jkms.2006.21.5.871
- Uefuji K, Ichikura T, Shinomiya N, Mochizuki H. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Anticancer research 2000;20:4279.
- Zhou XM, Wong BCY, Fan XM, et al. Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis 2001;22:1393-1397. https://doi.org/10.1093/carcin/22.9.1393
- Jiang X-H, Lam S-K, Lin MC, et al. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-β 1-dependent pathway. Oncogene 2002;21:6113-6122. https://doi.org/10.1038/sj.onc.1205778
- Sawaoka H, Kawano S, Tsuji S, et al. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins, Leukotrienes and Essential Fatty Acids 1998;59:313-316. https://doi.org/10.1016/S0952-3278(98)90079-5
- Romano M, Ricci V, Memoli A, et al. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. Journal of Biological Chemistry 1998;273:28560-28563. https://doi.org/10.1074/jbc.273.44.28560
- Uefuji K, Ichikura T, Mochizuki H, Shinomiya N. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. Journal of surgical oncology 1998;69:168-172. https://doi.org/10.1002/(SICI)1096-9098(199811)69:3<168::AID-JSO9>3.0.CO;2-0
- Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer ㄲesearch 1998;58:2929-2934.
- Chae SW, Sohn JH, Shin HS, Park YE. Expression of cyclooxygenase-2 protein in gastric carcinogenesis. Cancer Research and Treatment 2002;34:252-257. https://doi.org/10.4143/crt.2002.34.4.252
- Lehnert T, Deschner EE, Karmali RA, DeCosse JJ. Effect of flurbiprofen and 16, 16-dimethyl-prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats. I. Squamous epithelium and mesenchymal tissue. Journal of the National Cancer Institute 1987;78:923-929.
- Bespalov V, Troian D, Petrov A, Morozov V, Khavinson V. In- hibiting effect of thymogen on the development of tumors of the esophagus and forestomach induced by N-nitrososarcosine ethyl ester in rats. Eksperimental'naia Onkologiia 1989;11:23.
- Fu S-L, Wu Y-L, Zhang Y-P, Qiao M-M, Chen Y. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer. World journal of gastroenterology: WJG 2004;10:1971. https://doi.org/10.3748/wjg.v10.i13.1971
- Hu P, Yu J, Zeng Z, et al. Chemoprevention of gastric cancer by celecoxib in rats. Gut 2004;53:195-200. https://doi.org/10.1136/gut.2003.021477
- Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW. Aspirin use and risk of fatal cancer. Cancer Research 1993;53:1322-1327.
- Sorensen HT, Friis S, Norgard B, et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. British Journal of Cancer 2003;88:1687-1692. https://doi.org/10.1038/sj.bjc.6600945
- Cook NR, Lee I-M, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:47-55. https://doi.org/10.1001/jama.294.1.47
- Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, HAWK E. Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Research 2004;24:3177-3184.
- Epplein M, Nomura AM, Wilkens LR, Henderson BE, Kolonel LN. Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study. American Journal of Epidemiology 2009;170:507-514. https://doi.org/10.1093/aje/kwp162
- Abnet C, Freedman N, Kamangar F, Leitzmann M, Hollenbeck A, Schatzkin A. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. British Journal of Cancer 2009;100:551-557. https://doi.org/10.1038/sj.bjc.6604880
- Tian W, Zhao Y, Liu S, Li X. Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. European Journal of Cancer Prevention 2010;19:288-298. https://doi.org/10.1097/CEJ.0b013e328339648c
- Kim Y-I, Kim SY, Kim JH, et al. Long-term low-dose aspirin use reduces gastric cancer incidence: a nationwide cohort study. Cancer Research and Treatment: Official Journal of Korean Cancer Association 2016;48:798. https://doi.org/10.4143/crt.2015.117
- Niikura R, Hirata Y, Hayakawa Y, Kawahara T, Yamada A, Koike K. Effect of aspirin use on gastric cancer incidence and survival: A systematic review and meta-analysis. JGH Open 2020;4:117-125. https://doi.org/10.1002/jgh3.12226
- Bosetti C, Santucci C, Gallus S, Martinetti M, La Vecchia C. Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019. Annals of Oncology 2020.
- Akre K, Ekstrom A, Signorello L, Hansson L, Nyren O. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. British Journal of Cancer 2001;84:965-968. https://doi.org/10.1054/bjoc.2001.1702
- Wu C-Y, Wu M-S, Kuo KN, Wang C-B, Chen Y-J, Lin J-T. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. Journal of Clinical Oncology 2010;28:2952-2957. https://doi.org/10.1200/JCO.2009.26.0695
- Leung WK, Ng EK, Chan FK, et al. Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial. Clinical Cancer Research 2006;12:4766-4772. https://doi.org/10.1158/1078-0432.ccr-06-0693
- Wong BC, Zhang L, Ma J-l, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 2012;61:812-818. https://doi.org/10.1136/gutjnl-2011-300154